 |
인쇄하기
취소
|
Whanin to launch new natural drug preventing Alzheimer’s disease
Whanin Pharmaceutical says it has completed Phase III clinical trial for the natural extract INM-176 (Angelica gigas), an effective drug for the prevention and treatment of Alzheimer’s disease.
“If the natural drug is commercialized in the latter half 2012, it will open a path for Whanin to enter the domestic Alzheimer’s disease treatment market which reaches 100 billion won annually.
Res...
“If the natural drug is commercialized in the latter half 2012, it will open a path for Whanin to enter the domestic Alzheimer’s disease treatment market which reaches 100 billion won annually.
Res...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.